Back to mobile site

Citigroup Defending Puma Biotech (PBYI), "Buy The Dip", Maintains Buy

March 2, 2017 10:38 AM EST Send to a Friend
Citi maintains Buy on Puma Biotechnology (NASDAQ: PBYI) price target of $88.00.Mid-morning Citi analyst Dr. Yigal Nochomovitz is defending Puma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login